HBIO HARVARD BIOSCIENCE INC
Price Chart
Executive Summary
HBIO CEO received a non-cash grant of 75,000 shares, while a director made an open-market purchase of 10,000 shares for $48,700. The CEO's transaction is a routine award with no economic cost; the director's buying adds modest conviction.
Key Financial Metrics
Actionable Insight
Minor insider buying by a director adds slight positive sentiment, but CEO's grant is routine. Monitor for follow-up purchases or additional insider activity ahead of next earnings.
Key Facts
- CEO Duke John D was granted 75,000 shares at $0 (non-cash event, no market impact)
- Director Stephen J. Denelsky purchased 10,000 shares in the open market for $48,700
- Total open-market buying: $48,700 (0.2% of $24M market cap)
- No open-market selling or cash-related transactions
Financial Impact
$48,700 in open-market buying (0.2% of market cap), one non-cash grant
Risk Factors
- The CEO share grant may lead to future dilution if not part of a pre-approved plan
- Small market cap makes HBIO vulnerable to volatility from low-volume trades
Market Snapshot
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (2 trades, 7d window) | cluster-HBIO-1774273716700 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
|
Jun 2, 2026
7d ago
|
8-K
| $6.50 $6.48 | ▼ −0.31% | ▼ −0.71% | $6.04 (−7.08%) |
|
May 12, 2026
28d ago
|
8-K
| $5.41 $5.57 | ▲ +2.96% | ▲ +2.38% | $6.04 (+11.65%) |
|
May 12, 2026
28d ago
|
8-K
| $5.41 $5.57 | ▼ −2.96% | ▼ −2.38% | $6.04 (−11.65%) |
|
May 12, 2026
28d ago
|
Press Release
| $5.41 $5.57 | ▲ +2.96% | ▲ +2.38% | $6.04 (+11.65%) |
|
Mar 16, 2026
12w ago
|
Insider Cluster
| $5.01 $4.87 | ▼ −2.79% | ▼ −3.07% | $6.04 (+20.56%) |
|
Mar 16, 2026
12w ago
|
Insider Cluster
| $5.01 $4.87 | ▼ −2.79% | ▼ −3.07% | $6.04 (+20.56%) |
|
Mar 16, 2026
12w ago
|
Insider Cluster
| $5.01 $4.87 | ▼ −2.79% | ▼ −3.07% | $6.04 (+20.56%) |
|
Mar 12, 2026
12w ago
|
8-K / PRESS-RELEASE
| $4.90 $4.70 | ▼ −4.08% | ▼ −3.48% | $6.04 (+23.27%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access